Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roni Mamluk

Showing results (11-20 of 12) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 12 results.
The Journal of Clinical Endocrinology and Metabolism|February 10, 2015
Safety and efficacy of oral octreotide in acromegaly: results of a multicenter phase III trialShlomo Melmed, Vera Popovic, Martin Bidlingmaier, et al.
Mabs|March 2, 2010
Anti-tumor effect of CT-322 as an adnectin inhibitor of vascular endothelial growth factor receptor-2Roni Mamluk, Irvith M Carvajal, Brent A Morse, et al.
Pageof 2

Showing results (11-20 of 12) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 12 results.
The Journal of Clinical Endocrinology and Metabolism|February 10, 2015
Safety and efficacy of oral octreotide in acromegaly: results of a multicenter phase III trialShlomo Melmed, Vera Popovic, Martin Bidlingmaier, et al.
Mabs|March 2, 2010
Anti-tumor effect of CT-322 as an adnectin inhibitor of vascular endothelial growth factor receptor-2Roni Mamluk, Irvith M Carvajal, Brent A Morse, et al.
Pageof 2